Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04608409
Title Dose Escalation of Lapatinib With Paclitaxel in Ovarian Cancer
Recruitment Recruiting
Gender female
Phase Phase I
Variant Requirements No
Sponsors Frederick R. Ueland, M.D.
Indications

ovarian cancer

Therapies

Lapatinib + Paclitaxel

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.